(Reuters) - The U.S. Food and Drug Administration said an advisory panel will discuss the development of Ebola vaccines, days after an American health worker was flown back after being tested positive for Ebola in Sierra Leone. The federal health regulator would discuss the development of vaccines on May 12, it announced on its website on Wednesday. Mapp Biopharmaceutical’s ZMapp and a compound from Tekmira Pharmaceuticals Corp have so far shown they could cure non-human primates given injections of Ebola virus. Other companies that are testing potential treatments for the deadly infection are GlaxoSmithKline, Sarepta Pharmaceuticals Inc, Novavax Inc, Merck & Co and Johnson & Johnson.
from Health News Headlines - Yahoo News http://ift.tt/1BTPrCy
from Health News Headlines - Yahoo News http://ift.tt/1BTPrCy
via Lazahealth.org
No comments:
Post a Comment